uniQure (QURE) Change in Account Payables (2016 - 2026)
uniQure (QURE) posted quarterly Change in Account Payables of $625000.0 for Q2 2026, up 406.37% year-over-year from $123426.9 in Q2 2025, and up 212.21% quarter-over-quarter from -$557000.0 in Q1 2026.
Analysis
uniQure (QURE) Change in Account Payables (2016 - 2026) Analysis & Trends
uniQure's Change in Account Payables history runs 11 years deep, the most recent figure standing at $625000.0 for Q2 2026.
- In Q2 2026, Change in Account Payables rose 406.37% year-over-year to $625000.0; the TTM figure through Jun 2026 stood at -$302000.0 (down 135.87% YoY), while the FY2025 annual figure was -$2.7 million, down 275.46% from the prior year.
- Change in Account Payables for Q2 2026 stood at $625000.0, up from -$557000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $7.3 million in Q1 2022, with the low at -$3.6 million in Q3 2023.
- The 5-year median for Change in Account Payables is $61000.0 (2022), against an average of $221666.7.
- The sharpest annual moves came in 2024 and 2026: Change in Account Payables slumped 304.45% in 2024, then soared 406.37% in 2026.
- uniQure's Change in Account Payables stood at $4.7 million in 2022, then sank by 86.94% to $615000.0 in 2023, then surged by 230.41% to $2.0 million in 2024, then slumped by 150.15% to -$1.0 million in 2025, then soared by 161.33% to $625000.0 in 2026.
- Business Quant data shows QURE's Change in Account Payables at $625000.0 in Q2 2026, -$557000.0 in Q1 2026, and -$1.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 625,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 625,000.00 |
| Mar 31, 2026 | -557,000.00 |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | 649,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Mar 31, 2025 | -2.09 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | -918,000.00 |
| Mar 31, 2024 | -701,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Sep 30, 2023 | -3.57 Mn |
| Jun 30, 2023 | 449,000.00 |
| Mar 31, 2023 | -1.66 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | -3.10 Mn |
| Jun 30, 2022 | 326,000.00 |
| Mar 31, 2022 | 7.31 Mn |
| Dec 31, 2021 | -2.73 Mn |
| Sep 30, 2021 | -8.44 Mn |